Stockscreener 앱 받기
0.00
100.00%
-8.16
전일 마감가:
$8.16
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$564.26M
수익:
-
순이익/손실:
$-30.04M
주가수익비율:
0.00
EPS:
-1.58
순현금흐름:
$-27.38M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$8.345
Regulus Therapeutics Inc Stock (RGLS) Company Profile
명칭
Regulus Therapeutics Inc
전화
858-202-6300
주소
4224 CAMPUS POINT COURT, SAN DIEGO, CA
RGLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGLS
Regulus Therapeutics Inc
|
0.00 | 564.26M | 0 | -30.04M | -27.38M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Regulus Therapeutics Inc Stock (RGLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-08-02 | 개시 | Oppenheimer | Outperform |
| 2024-03-18 | 개시 | Leerink Partners | Outperform |
| 2018-03-28 | 개시 | B. Riley FBR, Inc. | Neutral |
| 2018-01-05 | 개시 | Leerink Partners | Outperform |
| 2017-06-13 | 재확인 | Chardan Capital Markets | Buy |
| 2017-03-06 | 재확인 | Wedbush | Outperform |
| 2017-01-30 | 다운그레이드 | Needham | Buy → Hold |
| 2017-01-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-12-07 | 재확인 | Chardan Capital Markets | Buy |
| 2016-11-02 | 재확인 | Needham | Buy |
| 2016-07-25 | 재확인 | Chardan Capital Markets | Buy |
| 2016-06-28 | 재확인 | Chardan Capital Markets | Buy |
| 2016-06-28 | 재확인 | FBR Capital | Outperform |
| 2016-06-28 | 재확인 | Needham | Buy |
| 2016-06-07 | 재확인 | Chardan Capital Markets | Buy |
| 2016-04-13 | 개시 | Chardan Capital Markets | Buy |
| 2015-12-04 | 개시 | Wells Fargo | Outperform |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2015-04-21 | 재개 | FBR Capital | Outperform |
| 2014-11-24 | 개시 | Deutsche Bank | Buy |
| 2014-08-07 | 재확인 | FBR Capital | Outperform |
| 2013-08-14 | 재확인 | Needham | Buy |
모두보기
Regulus Therapeutics Inc 주식(RGLS)의 최신 뉴스
Reversal Traders Monitor Regulus Therapeutics Inc. for EntryShort Term Buy Zone Stock Alerts Signal Entry - beatles.ru
What is the dividend policy of Regulus Therapeutics Inc. stockDynamic investment growth - jammulinksnews.com
What are the latest earnings results for Regulus Therapeutics Inc.Superior stock selection - jammulinksnews.com
What is Regulus Therapeutics Inc. company’s growth strategyAchieve breakthrough profits with smart strategies - jammulinksnews.com
How does Regulus Therapeutics Inc. compare to its industry peersOutstanding risk-reward balance - jammulinksnews.com
Does Regulus Therapeutics Inc. stock perform well during market downturnsConsistent wealth multiplication - jammulinksnews.com
How volatile is Regulus Therapeutics Inc. stock compared to the marketFree Consultation - jammulinksnews.com
When is Regulus Therapeutics Inc. stock expected to show significant growthUnlock daily market insights for better trades - jammulinksnews.com
What are analysts’ price targets for Regulus Therapeutics Inc. in the next 12 monthsGet professional advice for market timing - jammulinksnews.com
Is it the right time to buy Regulus Therapeutics Inc. stockUnlock powerful portfolio optimization tools - jammulinksnews.com
What analysts say about Regulus Therapeutics Inc. stockFree Market Volatility Navigation Tips - PrintWeekIndia
Is Regulus Therapeutics Inc. a good long term investmentTriple-digit growth rates - PrintWeekIndia
What drives Regulus Therapeutics Inc. stock priceHigh-yield trading alerts - Autocar Professional
Regulus Therapeutics Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
Regulus Therapeutics Inc (RGLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.23%
0.40%
자본화:
|
볼륨(24시간):